855-463-3320

Electrophysiology

Electrophysiology

Watchman™ Device: Breakthrough Therapy

Designed to prevent blood clots from exiting the left atrial appendage in patients with non-valvular atrial fibrillation, WATCHMAN debuted in the spring of 2015. Before WATCHMAN ever reached the market, MHVI’s EP specialists and interventional cardiologists spent eight years testing the device under multiple clinical trials.

Highlights of the Cardiac Electrophysiology (EP) Program

  • 5,000+ EP procedures each year
  • 15 board-certified specialists
  • 100+ WATCHMAN procedures to date
  • 13 regional outpatient clinic sites
  • 2 concurrent clinical trials—ASAP-TOO, Amulet™—to test the next generation of left atrial appendage occlusion devices

Fascinating Rhythms: Restoring Harmony In The Heart

The Cardiac Electrophysiology (EP) program at MedStar Heart & Vascular Institute (MHVI) is the region’s leading referral program and an internationally recognized contributor to advances in the field.

Electrophysiology
Zayd Eldadah, MD, PhD, Medical Director, Electrophysiology Lab MedStar Washington Hospital Center, MedStar Georgetown University Hospital

It features one of the largest, best equipped, and most sophisticated cardiac EP laboratories in North America today, enabling comprehensive management of even the most complex cardiac arrhythmias.

The program is a national leader in performing cryoablation procedures for atrial fibrillation and is also the mid-Atlantic’s most experienced facility with the WATCHMAN™ Device, the first FDA-approved left atrial appendage occlusion device for patients with atrial fibrillation. MHVI's EP program spans the spectrum of arrhythmia management in disease states, complexity and even geography.

Its team of fellowship-trained, board-certified cardiac electrophysiologists manages patients at multiple sites in Virginia, Maryland and the District of Columbia. Among the capabilities offered are advanced epicardial therapies for ventricular arrhythmias, specialized techniques for cardiac resynchronization therapy and—together with cardiac surgeons—combined endocardial and epicardial ablation for refractory atrial fibrillation, extraction of cardiac rhythm management device leads, and other complex procedures.


Read More in the Capabilities Booklet:

To make the book full screen, click on the last icon to the right.